FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W112418132> ?p ?o ?g. }

• W112418132 abstract "Duchenne Muscular Dystrophy (DMD) is a severe and progressive skeletal muscle wasting disease characterised by [Ca2+]-induced hyper-catabolism, and subsequently, a higher demand for energy production to modulate intracellular Ca2+ homeostasis, and protein degradation and synthesis pathways. The broad aim of this thesis was to elucidate potential defects in metabolism of the C57BL/10 mdx mouse model of DMD, and to determine the role of Ca2+ in any such defects. In particular, this thesis has examined the efficacy of the nutritional supplements creatine (Cr) and to a lesser extent, isolated whey protein (WP), in improving intracellular Ca2+ regulation, energy and protein balance and tissue architecture, thus alleviating a degree of the dystrophic pathology. 1. Whether the ATP-producing capacity of dystrophic mitochondria is defective remains largely contentious, and no study to date has directly quantified and contrasted ATP-production rate under the major macronutrient pathways feeding the mitochondria in either mdx hind limb or the more human DMD phenotype-like diaphragm. Chapter Three has demonstrated severely depressed mitochondrial ATP production rate (MAPR) of mdx diaphragm across all macronutrient substrate pathways, but to a lesser extent under protein metabolism, and in tibialis anterior (TA) across the sum of all macronutrient substrate pathways. Function of the electron transport chain complex II was not impaired in dystrophic diaphragm, but was notably depressed in TA. Citrate synthase activity was comparable to controls in both muscles, as was mitochondrial protein content. However, the susceptibility of dystrophic mitochondrial to mechanical damage during the mitochondria isolation process was significantly greater in mdx compared to controls, and in diaphragm compared to TA. It is postulated that mdx skeletal muscle has an intrinsic inability to utilise macronutrient substrates leading to substrate “back-up” and inhibition/down-regulation of key Krebs’ cycle enzymes, thus creating an intracellular “starvation” scenario. That protein metabolism was less affected than the other macronutrient substrate pathways suggests that a portion of the muscle hyper-catabolism observed in DMD may occur due to autophagy to increase amino acid funnelling to mitochondria for ATP production. 2. Supplementation of the high-energy storage nutrient Cr is demonstrably beneficial in maintaining muscle function, energy status and cell survival rate in human DMD and dystrophic mdx skeletal muscle. Long-term chronic dose supplementation regimes, however, have been associated with down-regulation of creatine transporter (CreaT) expression thus making such regimes futile in maintaining consistently high intramuscular PCr stores. Chapter Four has demonstrated successful prevention of CreaT mRNA down-regulation by a chronic dose in utero and life-long Cr supplementation protocol, and subsequently persistently elevated [PCr] compared to unsupplemented mdx skeletal muscle. This was associated with a drastically reduced amount of muscle damage as depicted by Evan’s blue dye (EBD) uptake into myofibres, and a lesser degree of damage to those fibres that were permeant to EBD. This unequivocally demonstrates that muscle wasting occurs secondary to metabolic compromise and failure to maintain ATP supply to intracellular mechanisms that promote cell survival. 3. Effective intracellular Ca2+ regulation by the sarcoplasmic reticulum (SR) is integral to muscle function and becomes of paramount importance to the maintenance of cell survival in conditions of increasing [Ca2+]i such as that evident in DMD. Chapter Five details an optimised method for the fluorometric quantitation of SR Ca2+ flux kinetics currently utilised by our laboratory. It was demonstrated that the SR Ca2+ ATPase (SERCA) preferentially utilises ATP produced by a linked creatine kinase (CK) system over both exogenously administered ATP and ATP produced by SR-linked glycolytic enzymes, and as such, SR Ca2+ uptake rate was considerably faster under these conditions. It was also demonstrated that high [ADP] proximal to the SR vesicles impairs the binding of Ca2+ to Fura-2 and that the presence of 25mM PCr and low [ADP] drastically reduces passive Ca2+ leak from the SR. Thus, this study provides sound rationale for the use of Cr supplementation to improve intracellular Ca2+ handling by the SR subsequent to increasing PCr stores and the buffering of rising [ADP] during metabolic compromise. 4. It has been suggested that the beneficial effects observed in human DMD and dystrophic mdx skeletal muscle following Cr supplementation result from an improved capacity for intracellular Ca2+ handling by the SR and, therefore, delayed degenerative progression. Chapter Six has demonstrated no direct modulatory effect for Cr supplementation on SERCA or RyR function such to increase/decrease SR Ca2+ uptake, leak or release rates, but postulates that the benefit imparted by Cr supplementation is in maintaining maximum uptake (and subsequently release) velocity secondary to buffering rising [ADP] and collapse of the ATP:ADP ratio proximal to the SR. This study has also investigated the effects of supplementation with WP and a Cr+WP combination. As with Cr supplementation, WP induced no direct modulation of SR Ca2+ flux kinetics. Both supplements were shown to modulate differential expression of specific intracellular protein pools, although not necessarily net protein accretion. It is speculated that modification of expressed intracellular protein pools permits the “switching” of dystrophic mdx skeletal muscle from a “functional” phenotype to a “cell survival” phenotype, and that this is inhibited in unsupplemented muscle by a lack of amino acid and energy resources. It was also apparent that Cr and WP supplementation exerted different effects on tissue architecture maintenance. Cr supplementation increased the proportional area of functional muscle tissue and decreased non-muscle “gap” areas thus suggesting a role in muscle hypertrophy, where as Cr+WP combined increased active/recent degeneration and regeneration and the proportion of centrally-nucleated previously damaged fibres compared to peripherally-nucleated undamaged fibres in functional muscle tissue, thus indicating a potentially damaging effect. Collectively, the studies comprising this thesis indicate that the progressive skeletal muscle wasting evident in DMD is closely related to dissipating energy stores, and that the primary disease pathology may, therefore, be an intrinsic metabolic defect caused by the DMD genotype that subsequently induces Ca2+ dys-regulation. Cr supplementation was shown to provide several benefits to dystrophic mdx skeletal muscle architecture, including reduced severity of degenerative cycles, maintenance of muscle tissue and reduced proportional area of non-muscle tissue secondary to increased intramuscular [PCr]. The findings of Chapter Five suggest that Cr supplementation modulates its effect by maintaining normal [PCr] and a high ATP:ADP and PCr:Cr proximal to the SR, such to maintain maximum Ca2+ uptake velocity and reduce passive Ca2+ leak. Both Cr and WP supplementation also seem to modulate intracellular protein synthesis such to increase the capacity for myofibre survival. Thus, these supplements could be of benefit in the adjunct treatment of DMD, and warrant further investigation as to their long-term and mechanistic efficacy." @default.
• W112418132 created "2016-06-24" @default.
• W112418132 creator A5012060954 @default.
• W112418132 date "2007-01-01" @default.
• W112418132 modified "2023-09-26" @default.
• W112418132 title "Impaired metabolism in X-linked muscular dystrophy: experimental evaluation of potential therapies to improve calcium regulation, bioenergetics and muscle architecture" @default.
• W112418132 cites W10680619 @default.
• W112418132 cites W116341769 @default.
• W112418132 cites W120704073 @default.
• W112418132 cites W1208244564 @default.
• W112418132 cites W1260453475 @default.
• W112418132 cites W133994192 @default.
• W112418132 cites W139026977 @default.
• W112418132 cites W1444118799 @default.
• W112418132 cites W1480415840 @default.
• W112418132 cites W1482629448 @default.
• W112418132 cites W1483833346 @default.
• W112418132 cites W148403024 @default.
• W112418132 cites W1485537415 @default.
• W112418132 cites W1495930413 @default.
• W112418132 cites W1496871717 @default.
• W112418132 cites W1500047101 @default.
• W112418132 cites W1505685265 @default.
• W112418132 cites W1506154298 @default.
• W112418132 cites W1514743713 @default.
• W112418132 cites W151533114 @default.
• W112418132 cites W1515343735 @default.
• W112418132 cites W1516828999 @default.
• W112418132 cites W1518262295 @default.
• W112418132 cites W1534652943 @default.
• W112418132 cites W1536343685 @default.
• W112418132 cites W1549895552 @default.
• W112418132 cites W1552023984 @default.
• W112418132 cites W1555531912 @default.
• W112418132 cites W1556485756 @default.
• W112418132 cites W1559018234 @default.
• W112418132 cites W1559546823 @default.
• W112418132 cites W1559795048 @default.
• W112418132 cites W1560838288 @default.
• W112418132 cites W1563422013 @default.
• W112418132 cites W1573193689 @default.
• W112418132 cites W1575714747 @default.
• W112418132 cites W1577734122 @default.
• W112418132 cites W1591572497 @default.
• W112418132 cites W1592698849 @default.
• W112418132 cites W1596427554 @default.
• W112418132 cites W1608141030 @default.
• W112418132 cites W1620546484 @default.
• W112418132 cites W1628785169 @default.
• W112418132 cites W1688774372 @default.
• W112418132 cites W1705241395 @default.
• W112418132 cites W1733860546 @default.
• W112418132 cites W174097160 @default.
• W112418132 cites W1747748421 @default.
• W112418132 cites W1748754899 @default.
• W112418132 cites W1752377265 @default.
• W112418132 cites W1803792965 @default.
• W112418132 cites W1804213683 @default.
• W112418132 cites W1821085646 @default.
• W112418132 cites W1832331880 @default.
• W112418132 cites W1849159432 @default.
• W112418132 cites W1850312794 @default.
• W112418132 cites W1861332892 @default.
• W112418132 cites W188536477 @default.
• W112418132 cites W1889871926 @default.
• W112418132 cites W1895697393 @default.
• W112418132 cites W1906240697 @default.
• W112418132 cites W1906846423 @default.
• W112418132 cites W1914136894 @default.
• W112418132 cites W1930882462 @default.
• W112418132 cites W1936284749 @default.
• W112418132 cites W1938282147 @default.
• W112418132 cites W1938320888 @default.
• W112418132 cites W1941910566 @default.
• W112418132 cites W1949811505 @default.
• W112418132 cites W195031074 @default.
• W112418132 cites W1952579501 @default.
• W112418132 cites W1952906612 @default.
• W112418132 cites W1964142515 @default.
• W112418132 cites W1964393311 @default.
• W112418132 cites W1964531354 @default.
• W112418132 cites W1964709412 @default.
• W112418132 cites W1964881119 @default.
• W112418132 cites W1965029487 @default.
• W112418132 cites W1966050731 @default.
• W112418132 cites W1967138034 @default.
• W112418132 cites W1967330198 @default.
• W112418132 cites W1967344358 @default.
• W112418132 cites W1967523918 @default.
• W112418132 cites W1968306591 @default.
• W112418132 cites W1968869845 @default.
• W112418132 cites W1968951897 @default.
• W112418132 cites W1969262971 @default.
• W112418132 cites W1969471587 @default.
• W112418132 cites W1969683520 @default.
• W112418132 cites W1969983508 @default.
• W112418132 cites W1970269001 @default.
• W112418132 cites W1970506684 @default.
• W112418132 cites W1970734629 @default.
• W112418132 cites W1970848490 @default.

• next